Comparison of the Efficacy and Safety Profiles of Different P2Y12 Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction in the COVID-19 Era

Background/aim: Coronavirus Disease 2019 (COVID-19) is characterized by an increased risk of thrombotic and hemorrhagic events resulting from endothelial dysfunction. In patients with ST-elevation myocardial infarction (STEMI), the dual antiplatelet therapy used to reduce mortality may increase the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaya, Ali̇ N, Şahin, Mürsel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509489/
https://www.ncbi.nlm.nih.gov/pubmed/37736426
http://dx.doi.org/10.7759/cureus.43829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509489/
https://www.ncbi.nlm.nih.gov/pubmed/37736426
http://dx.doi.org/10.7759/cureus.43829

Ejemplares similares